| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000044301 |
| Receipt No. | R000050595 |
| Scientific Title | Cross-sectional study on bile acid reflux and Barrett's esophagus, Gastro Esophageal Reflux Disease |
| Date of disclosure of the study information | 2021/05/24 |
| Last modified on | 2022/05/25 (Ver. 5) |
| Basic information | ||
| Public title | Cross-sectional study on bile acid reflux and Barrett's esophagus, Gastro Esophageal Reflux Disease | |
| Acronym | Bile Acid Reflux and Barrett's Esophagus, GERD | |
| Scientific Title | Cross-sectional study on bile acid reflux and Barrett's esophagus, Gastro Esophageal Reflux Disease | |
| Scientific Title:Acronym | Bile Acid Reflux and Barrett's Esophagus, GERD | |
| Region |
|
|
| Condition | ||
| Condition | Barrett's esophagus, Gastro Esophageal Reflux Disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Examine the relationship between bile acids refluxed into the stomach and Barrett's esophagus and Gastro Esophageal Reflux Disease. |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the relationship between intragastric bile acid concentration and patient background, esophagogastric junction cancer, and gastric reservoir fluid color. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relationship between intragastric bile acid concentration and Barrett's esophagus and Gastro Esophageal Reflux Disease |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled to undergo upper gastrointestinal endoscopy
The participants themselves must have received sufficient explanation of the research and given written consent. |
|||
| Key exclusion criteria | Patients who require emergency treatment and are difficult to observe normally | |||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Hospital | ||||||
| Division name | Endoscopy Center / Department of Gastroenterology and Hepatology | ||||||
| Zip code | 236-0004 | ||||||
| Address | 3-9 Fukuura Kanazawa-ku Yokohama-shi Kanaga wa-ken, Japan | ||||||
| TEL | 045-787-2800 | ||||||
| t196038d@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Hospital | ||||||
| Division name | Endoscopy Center / Department of Gastroenterology and Hepatology | ||||||
| Zip code | 236-0004 | ||||||
| Address | 3-9 Fukuura Kanazawa-ku Yokohama-shi Kanagawa-ken, Japan | ||||||
| TEL | 045-787-2800 | ||||||
| Homepage URL | |||||||
| t196038d@yokohama-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama City University School of Medicine Department of Gastroenterology and Hepatology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yokohama City University Certified Institutional Review Board |
| Address | 3-9 Fukuura Kanazawa-ku Yokohama-shi Kanagawa-ken, Ja pan, Kanagawa, Kanagawa |
| Tel | 045-370-7627 |
| rinri@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 436 | ||||||
| Results | Patients with Barrett's esophagus have higher total bile acid concentration (total BA) and certain bile acid fraction concentrations (e.g. Conj CDCA).
The Spearman rank correlation coefficient between total BA and Conj CDCA is strongly correlated at 0.95. Total BA, Conj CA, and Conj CDCA are strongly correlated with the color of gastric juice. The color of the intragastric liquid was quantified to obtain a cutoff value (Youden Index) for the presence of Barrett's esophagus (YI 11.3). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | The study subjects were patients who underwent gastroscopy at Yokohama City University Hospital from May 7, 2021 to September 31, 2021. | ||||||
| Participant flow | Gastroscopy was performed on patients who had refrained from eating and drinking for a certain period of time, and the esophagus, stomach, and duodenum were observed, intragastric fluid was collected, and biopsies were taken if necessary. | ||||||
| Adverse events | none | ||||||
| Outcome measures | background information (gender, age14,15, height, weight (BMI; Body Mass Index16), life history, preferences, H. pylori infection/elimination, previous history, surgical history, complications, and regular medications), last time they drank water, purpose of gastroscopy, Color of intragastric liquid and bile acid concentrations in stomach | ||||||
| Plan to share IPD | none | ||||||
| IPD sharing Plan description | none | ||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Gastric fluid and clinical information obtained in the course of normal medical care should be collected.
Gastric fluid and endoscopic findings will be collected at the time of upper gastrointestinal endoscopy (including pathology results). Based on the information obtained, the relationship between intragastric bile acid concentration and Barrett's esophagus and Gastro Esophageal Reflux Disease will be investigated. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000050595 |